Connor, Clark & Lunn Investment Management (CC&L)
RNA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Avidity Biosciences RNA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-217,855
Closed -$6.34M – 1575
2024
Q4 		$6.34M Buy
217,855
+830
+0.4% +$24.1K 0.03% 422
2024
Q3 		$9.97M Buy
217,025
+211,512
+3,837% +$9.71M 0.05% 281
2024
Q2 		$225K Buy
+5,513
New +$225K ﹤0.01% 1241